Pre-junctional alpha2-adrenoceptors modulation of the nitrergic transmission in the pig urinary bladder neck

Neurourol Urodyn. 2007;26(4):578-583. doi: 10.1002/nau.20368.

Abstract

Aims: To investigate the nitric oxide (NO)-mediated nerve relaxation and its possible modulation by pre-junctional alpha2-adrenoceptors in the pig urinary bladder neck.

Methods: Urothelium-denuded bladder neck strips were dissected, and mounted in isolated organ baths containing a physiological saline solution (PSS) at 37 degrees C and continuously gassed with 5% CO2 and 95% O2, for isometric force recording. The relaxations to transmural nerve stimulation (electrical field stimulation [EFS]) or exogenously applied NO were carried out on strips pre-contracted with 1 microM phenylephrine (PhE) and treated with guanethidine (10 microM) and atropine (0.1 microM), to block noradrenergic neurotransmission and muscarinic receptors, respectively.

Results: EFS (0.2-1 Hz, 1 msec duration, 20 sec trains, current output adjusted to 75 mA) evoked frequency-dependent relaxations which were abolished by the neuronal voltage-activated Na+ channel blocker tetrodotoxin (TTX, 1 microM). These responses were potently reduced by the nitric oxide synthase (NOS) inhibitor NG-nitro-L-arginine (L-NOARG, 30 microM) and further reversed by the NO synthesis substrate L-arginine (L-ARG, 3 mM). The alpha2-adrenoceptor agonist BHT-920 (2 microM) reduced the electrically evoked relaxations, its effectiveness being higher on the responses induced by low frequency stimulation. BHT-920-elicited reductions were fully reversed by the alpha2-adrenoceptor antagonist rauwolscine (RAW, 1 microM). Exogenous NO (1 microM-1 mM) induced concentration-dependent relaxations which were not modified by BHT-920, thus eliminating a possible post-junctional modulation.

Conclusions: These results indicate that NO is involved in the non-adrenergic non-cholinergic (NANC) inhibitory neurotransmission in the pig urinary bladder neck, the release of NO from intramural nerves being modulated by pre-junctional alpha2-adrenoceptor stimulation.

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Arginine / pharmacology
  • Autonomic Nervous System / drug effects
  • Autonomic Nervous System / physiology
  • Azepines / pharmacology
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology
  • Female
  • Isometric Contraction / drug effects
  • Male
  • Muscle Relaxation / drug effects
  • Muscle Relaxation / physiology
  • Nitric Oxide / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase Type I / antagonists & inhibitors
  • Nitroarginine / pharmacology
  • Receptors, Adrenergic, alpha-2 / physiology*
  • Swine
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology*
  • Tetrodotoxin / pharmacology
  • Urinary Bladder / drug effects
  • Urinary Bladder / innervation*
  • Urinary Bladder / physiology*
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Azepines
  • Enzyme Inhibitors
  • Receptors, Adrenergic, alpha-2
  • Nitroarginine
  • Yohimbine
  • Nitric Oxide
  • Tetrodotoxin
  • talipexole
  • Arginine
  • Nitric Oxide Synthase Type I